目的:研究腹腔镜辅助近端胃切除术(laparoscopic-assisted proximal gastrectomy,LAPG)和开腹全胃切除术(open proximalgastrectomy,OPG)治疗SiewertⅡ型和Ⅲ型食管胃结合部腺癌(adenocarcinoma of the esophagogastric junction,AEG)...目的:研究腹腔镜辅助近端胃切除术(laparoscopic-assisted proximal gastrectomy,LAPG)和开腹全胃切除术(open proximalgastrectomy,OPG)治疗SiewertⅡ型和Ⅲ型食管胃结合部腺癌(adenocarcinoma of the esophagogastric junction,AEG)的临床疗效。方法:回顾性分析蚌埠医学院第一附属医院2015年2月至2017年2月收治的116例行近端胃切除的SiewertⅡ型和Ⅲ型AEG患者的临床资料,其中LAPG组48例、OPG组68例。分析两组患者的临床病理特征、术中情况、根治效果与肿瘤复发情况。结果:两组患者手术均顺利完成,无围手术期死亡。LAPG组患者平均手术时间为(3.46±0.46)h,长于OPG组的(2.68±0.68)h;平均术中出血量为(108±46.8)mL,少于OPG组的(236±86.6)mL;胃肠功能恢复时间为(2.56±0.56)d,短于OPG组的(3.82±0.86)d;术后平均住院时间为(12.24±1.86)d,少于OPG组的(14.68±2.89)d;近端切缘(3.06±0.56)cm长于OPG组的(2.38±0.68)cm(均P<0.05)。两组患者的清扫淋巴结数目、远端切缘、术后并发症发生率,差异均无统计学意义(P>0.05)。结论:LAPG在治疗SiewertⅡ型和Ⅲ型AEG患者的根治效果、术后并发症及肿瘤复发方面与开放手术相当;LAPG具有术中出血少、胃肠功能恢复快、住院时间短的优势,近端切缘更长。展开更多
目的:观察补肾益髓(Bu Shen Yi Sui,BSYS)方及其拆方补肾(Bu Shen,BS)和化痰活血(Hua Tan Huo Xue,HTHX)方对实验性自身免疫性脑脊髓炎(Experimental Autoimmune Encephalomyelitis,EAE)小鼠脑和脊髓中脑源性神经营养因子(Brain-derived...目的:观察补肾益髓(Bu Shen Yi Sui,BSYS)方及其拆方补肾(Bu Shen,BS)和化痰活血(Hua Tan Huo Xue,HTHX)方对实验性自身免疫性脑脊髓炎(Experimental Autoimmune Encephalomyelitis,EAE)小鼠脑和脊髓中脑源性神经营养因子(Brain-derived Neurotrophic Factor,BDNF)与受体Trk B的影响。方法:将EAE造模小鼠于当天和第7天背部皮下注射髓鞘少突胶质细胞糖蛋白(Myelin Oligodendrocyte Glycoprotein,MOG)35-55抗原,并在免疫当天和第2天后腹腔注射百日咳毒素(Pertussis toxin,PTX)。每日对小鼠进行不同药物的灌胃,并于造模第20和40天分别取脑和脊髓,采用实时荧光定量RTPCR(qRT-PCR)与Western Blot法检测BDNF和Trk B的表达。结果:BSYS及其拆方BS方与HTHX方均可明显上调EAE小鼠脑和脊髓BDNF和Trk B mRNA与蛋白的表达,与模型组比较,差异均有统计学意义(P<0.05或P<0.01)。BSYS方作用优于其BS与HTHX方,但差异无统计学意义(P>0.05)。结论:BSYS及其拆方促进轴突修复的作用可能与增强BDNF/Trk B表达有关,BSYS全方更有显著趋势。展开更多
Azalomycin F<sub>5a</sub>, a 36-membered macrocyclic lactone isolated from several streptomyces strains, presented remarkable anti-methicillin-resistant Staphylococcus aureus (MRSA) activities. To improve ...Azalomycin F<sub>5a</sub>, a 36-membered macrocyclic lactone isolated from several streptomyces strains, presented remarkable anti-methicillin-resistant Staphylococcus aureus (MRSA) activities. To improve its anti-MRSA potential and to evaluate the probability of MRSA resistant to it before development, the anti-MRSA activities of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub> were first evaluated using checkerboard assay. Then the minimal concentration inhibiting colony formation by 99% (MIC<sub>99</sub>) and mutant prevention concentration (MPC) of azalomycin F<sub>5a</sub> alone and in combination with vitamin K<sub>3</sub> against MRSA were determined using agar plates with linear antimicrobial concentration decrease. The fractional inhibitory concentration indexes (FICIs) of 0.25 - 0.50 showed the synergistic activity of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub>. The mutant selection windows (MSWs, MIC<sub>99</sub>-MPC) of azalomycin F<sub>5a</sub> alone against MRSA tested were 2.07 - 6.40 μg/mL, and the MPCs of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub> against MRSA tested were 1.60 - 3.20 μg/mL. These indicated that the MPCs of azalomycin F<sub>5a</sub> in combination could drop down to below its MIC<sub>99</sub> alone. According to the hypothesis of MSW, the narrower MSWs of azalomycin F<sub>5a </sub>alone, even closed MSWs in combination with vitamin K<sub>3</sub>, together with their synergistic anti-MRSA activities, indicated that azalomycin F<sub>5a </sub>had a good potential to develop as a new antimicrobial agent.展开更多
文摘目的:研究腹腔镜辅助近端胃切除术(laparoscopic-assisted proximal gastrectomy,LAPG)和开腹全胃切除术(open proximalgastrectomy,OPG)治疗SiewertⅡ型和Ⅲ型食管胃结合部腺癌(adenocarcinoma of the esophagogastric junction,AEG)的临床疗效。方法:回顾性分析蚌埠医学院第一附属医院2015年2月至2017年2月收治的116例行近端胃切除的SiewertⅡ型和Ⅲ型AEG患者的临床资料,其中LAPG组48例、OPG组68例。分析两组患者的临床病理特征、术中情况、根治效果与肿瘤复发情况。结果:两组患者手术均顺利完成,无围手术期死亡。LAPG组患者平均手术时间为(3.46±0.46)h,长于OPG组的(2.68±0.68)h;平均术中出血量为(108±46.8)mL,少于OPG组的(236±86.6)mL;胃肠功能恢复时间为(2.56±0.56)d,短于OPG组的(3.82±0.86)d;术后平均住院时间为(12.24±1.86)d,少于OPG组的(14.68±2.89)d;近端切缘(3.06±0.56)cm长于OPG组的(2.38±0.68)cm(均P<0.05)。两组患者的清扫淋巴结数目、远端切缘、术后并发症发生率,差异均无统计学意义(P>0.05)。结论:LAPG在治疗SiewertⅡ型和Ⅲ型AEG患者的根治效果、术后并发症及肿瘤复发方面与开放手术相当;LAPG具有术中出血少、胃肠功能恢复快、住院时间短的优势,近端切缘更长。
文摘Azalomycin F<sub>5a</sub>, a 36-membered macrocyclic lactone isolated from several streptomyces strains, presented remarkable anti-methicillin-resistant Staphylococcus aureus (MRSA) activities. To improve its anti-MRSA potential and to evaluate the probability of MRSA resistant to it before development, the anti-MRSA activities of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub> were first evaluated using checkerboard assay. Then the minimal concentration inhibiting colony formation by 99% (MIC<sub>99</sub>) and mutant prevention concentration (MPC) of azalomycin F<sub>5a</sub> alone and in combination with vitamin K<sub>3</sub> against MRSA were determined using agar plates with linear antimicrobial concentration decrease. The fractional inhibitory concentration indexes (FICIs) of 0.25 - 0.50 showed the synergistic activity of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub>. The mutant selection windows (MSWs, MIC<sub>99</sub>-MPC) of azalomycin F<sub>5a</sub> alone against MRSA tested were 2.07 - 6.40 μg/mL, and the MPCs of azalomycin F<sub>5a</sub> in combination with vitamin K<sub>3</sub> against MRSA tested were 1.60 - 3.20 μg/mL. These indicated that the MPCs of azalomycin F<sub>5a</sub> in combination could drop down to below its MIC<sub>99</sub> alone. According to the hypothesis of MSW, the narrower MSWs of azalomycin F<sub>5a </sub>alone, even closed MSWs in combination with vitamin K<sub>3</sub>, together with their synergistic anti-MRSA activities, indicated that azalomycin F<sub>5a </sub>had a good potential to develop as a new antimicrobial agent.
